Company Pharmaron Beijing Co., Ltd.

Equities

300759

CNE100003JW4

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 2026-01-23			5-day change	1st Jan Change
31.11 ^CNY	-0.61%		-2.60%	+9.43%

Jan. 23	CMB International Starts Pharmaron Beijing at Buy with 38.08 Yuan Price Target	MT
Jan. 22	Pharmaron Beijing Completes HK$1.32 Billion Share Offering	MT

Business description: Pharmaron Beijing Co., Ltd.

Pharmaron Beijing Co. is specialised in the research, development and manufacturing of small molecule drugs, cell therapies and gene therapies. Net sales break down by activity as follows:

- laboratory services (61.3%);

- development and production of chemical processes and formulations (23.5%);

- clinical research services (12.8%);

- other (2.4%);

Net sales are distributed geographically as follows: China (17.1%), Asia (2.6%), North America (64.2%), Europe (15.6%) and other (0.5%).

Number of employees: 21,370

Sales by Activity: Pharmaron Beijing Co., Ltd.

Fiscal Period: December	2020 (CNY)	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)
Laboratory Services (Excl. Macromolecule and Cell and Gene Therapy Services)	-	4.57B	6.24B	-	7.05B
Laboratory Services	3.26B	-	-	6.66B	-
Chemical and formulation process development and manufacturing services	1.22B	1.75B	2.41B	2.71B	2.99B
Clinical Research Services	629M	956M	1.39B	1.74B	1.83B
Macromolecule and Cell and Gene Therapy Services	-	151M	195M	425M	408M
Others	19.55M	24.48M	26.19M	4.61M	6.4M

See all business segments

Geographical breakdown of sales: Pharmaron Beijing Co., Ltd.

Fiscal Period: December	2020 (CNY)	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)
North America	-	4.78B	6.64B	7.4B	7.85B
Europe	-	1.16B	1.48B	1.84B	2.27B
Mainland China	-	1.27B	1.88B	1.97B	1.85B
Asia (Excluding Chinese Mainland)	-	193M	233M	269M	264M
Others	-	33.96M	25.01M	48.87M	39.51M
Foreign	4.43B	-	-	-	-
China	700M	-	-	-	-

See all geographic segments

Executive Committee: Pharmaron Beijing Co., Ltd.

Manager	Title	Age	Since
Xiao Qiang Lou PSD	President	57	-
Bei Zheng PRN	Corporate Officer/Principal	59	2016-10-26
Bo Liang Lou CEO	Chief Executive Officer	62	2016-10-26
Hua Yang CTO	Chief Tech/Sci/R&D Officer	64	2016-10-26
Lan Zhang PRN	Corporate Officer/Principal	44	-

See PHARMARON BEIJING CO., LTD. governance

Composition of the Board of Directors: Pharmaron Beijing Co., Ltd.

Director	Title	Age	Since
Bo Liang Lou CHM	Chairman	62	2016-10-26
Bei Zheng BRD	Director/Board Member	59	2016-10-26
Ke Xin Yang CHM	Chairman	64	2016-10-26
Xiao Qiang Lou BRD	Director/Board Member	57	2016-10-26
Jia Qing Li BRD	Director/Board Member	53	2007-02-28
Lan Zhang BRD	Director/Board Member	44	2016-10-26
Jian Yu BRD	Director/Board Member	52	2020-07-22
Shu Feng BRD	Director/Board Member	41	2020-12-10
Li Hua Li BRD	Director/Board Member	62	2016-10-26

Composition of the Board of Directors

Shareholders: Pharmaron Beijing Co., Ltd.

Name	Equities	%	Valuation
CITIC M&A Fund Management Co. Ltd. 18.62 %	264,598,500	18.62 %	1 076 M ¥
Bo Liang Lou 12.7 %	180,496,500	12.7 %	734 M ¥
Zhong Ou Asset Management Co., Ltd 4.533 %	64,410,398	4.533 %	262 M ¥
Xiao Qiang Lou 3.89 %	55,270,039	3.89 %	225 M ¥
Hwabao WP Fund Management Co., Ltd. 2.108 %	29,946,981	2.108 %	122 M ¥

Name	Equities	%	Valuation
Norges Bank Investment Management 4.824 %	14,545,724	4.824 %	37 M ¥
Merrill Lynch International (Investment Management) 4.126 %	12,440,143	4.126 %	31 M ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt) 0.905 %	2,728,800	0.905 %	7 M ¥
ICBC UBS Asset Management Co. Ltd. 0.8464 %	2,552,285	0.8464 %	6 M ¥
Yinhua Fund Management Co., Ltd. 0.3947 %	1,190,300	0.3947 %	3 M ¥

Name	Equities	%	Valuation
Xiao Qiang Lou 70.66 %	45,405,037	70.66 %	185 M ¥
Bei Zheng 18.38 %	11,812,500	18.38 %	48 M ¥

List of PHARMARON BEIJING CO., LTD. shareholders

Company details: Pharmaron Beijing Co., Ltd.

Pharmaron Beijing Co., Ltd.

8/F, Building 1

100176, Beijing

http://www.pharmaron.cn

address Pharmaron Beijing Co., Ltd.(300759)

Group companies: Pharmaron Beijing Co., Ltd.

Name	Category and Sector
Pharmaron (Hong Kong) International Ltd.
Pharmaron (Hong Kong) International Ltd.

See all subsidiaries

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
PHARMARON BEIJING CO., LTD.	-0.61%	-2.60%	+22.43%	-43.57%	7.57B
LONZA GROUP AG	+0.04%	-0.68%	-6.02%	+14.33%	49.48B
IQVIA HOLDINGS INC.	-1.56%	-1.00%	+15.16%	+4.22%	40.07B
BEONE MEDICINES AG	+0.15%	+0.33%	+52.79%	+27.21%	37.55B
CELLTRION, INC.	+1.92%	+1.44%	+22.35%	+42.46%	31.67B
REVOLUTION MEDICINES, INC.	-0.99%	-2.20%	+186.97%	+320.56%	22.74B
MEDPACE HOLDINGS, INC.	-3.01%	-3.74%	+70.91%	+152.23%	16.56B
Average	-0.58%	-0.43%	+52.09%	+73.92%	29.38B
Weighted average by Cap.	-0.35%	-0.28%	+41.80%	+61.88%